{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:11:20Z","timestamp":1761102680421,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma &amp; Immunology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.anai.2023.01.037","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T21:36:34Z","timestamp":1675805794000},"page":"671-672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Severe atopic dermatitis improved with identification and targeted therapy of cholinergic urticaria"],"prefix":"10.1016","volume":"130","author":[{"given":"Ashley Y.","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica H.","family":"Plager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6468-7230","authenticated-orcid":false,"given":"Basil M.","family":"Kahwash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anai.2023.01.037_bib0001","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40257-022-00728-6","article-title":"Cholinergic urticaria: subtype classification and clinical approach","volume":"24","author":"Fukunaga","year":"2023","journal-title":"Am J Clin Dermatol"},{"issue":"7","key":"10.1016\/j.anai.2023.01.037_bib0002","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.jaip.2020.01.025","article-title":"Clinical management of exercise-induced anaphylaxis and cholinergic urticaria","volume":"8","author":"Geller","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2023.01.037_bib0003","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jaip.2015.09.021","article-title":"Cholinergic urticaria with anaphylaxis: an underrecognized clinical entity","volume":"4","author":"Vadas","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2023.01.037_bib0004","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/archderm.1987.01660280064024","article-title":"Cholinergic urticaria. A clinical and histologic study","volume":"123","author":"Hirschmann","year":"1987","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2023.01.037_bib0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/ACI.0000000000000298","article-title":"Diagnostic utility of challenge procedures for physical urticaria\/angioedema syndromes: a systematic review","volume":"16","author":"Cuervo-Pardo","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.01.037_bib0006","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jaip.2018.03.007","article-title":"How to approach chronic inducible urticaria","volume":"6","author":"Maurer","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.anai.2023.01.037_bib0007","first-page":"1367","article-title":"Exercise-induced anaphylaxis and urticaria","volume":"64","author":"Hosey","year":"2001","journal-title":"Am Fam Phys"},{"issue":"1","key":"10.1016\/j.anai.2023.01.037_bib0008","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2133.1978.tb07332.x","article-title":"Tests to establish the diagnosis in cholinergic urticaria","volume":"98","author":"Commens","year":"1978","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.anai.2023.01.037_bib0009","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0091-6749(81)90209-8","article-title":"Identification of a new physically induced urticaria: cold-induced cholinergic urticaria","volume":"68","author":"Kaplan","year":"1981","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.01.037_bib0010","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.jaip.2018.12.025","article-title":"Efficacy and safety of omalizumab (Xolair) for cholinergic urticaria in patients unresponsive to a double dose of antihistamines: a randomized mixed double-blind and open-label placebo-controlled clinical trial","volume":"7","author":"Gastaminza","year":"2019","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Annals of Allergy, Asthma &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623000893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623000893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:32:32Z","timestamp":1761053552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120623000893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1081120623000893"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2023.01.037","relation":{},"ISSN":["1081-1206"],"issn-type":[{"type":"print","value":"1081-1206"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe atopic dermatitis improved with identification and targeted therapy of cholinergic urticaria","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2023.01.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}